Suppr超能文献

药物和聚合物的一致释放:无定形固体分散体溶解中的“最佳点”。

Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.

机构信息

Department of Industrial and Physical Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.

Department of Industrial and Physical Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA; Drug Product Science & Technology, Bristol-Myers Squibb Company, One Squibb Drive, New Brunswick, NJ 08903, USA.

出版信息

J Control Release. 2019 Mar 28;298:68-82. doi: 10.1016/j.jconrel.2019.01.039. Epub 2019 Feb 4.

Abstract

Liquid-liquid phase separation (LLPS) occurs following amorphous solid dispersion (ASD) dissolution when the drug concentration exceeds the "amorphous solubility", and is emerging as an important characteristic of formulations that may enhance the oral bioavailability of poorly soluble drugs. The purpose of this research was to identify criteria that impact the rate and extent of drug release and hence the occurrence or not of LLPS upon ASD dissolution. Specifically, the effect of drug log P, phase behavior of the hydrated but undissolved ASD matrix and the relative dissolution rates of drug and polymer were studied as a function of drug loading, using nilvadipine (Nil) (ClogP = 3.04) and cilnidipine (Cil) (ClogP = 5.54) as model drugs. The model polymer was poly (vinylpyrrolidone-co-vinyl acetate) (PVPVA). Nil-PVPVA and Cil-PVPVA ASDs with different drug loadings were prepared. Surface area normalized dissolution rates of both the drug and the polymer from ASD tablets were studied. At a similar and relatively low drug loading (<20% w/w drug), dissolution of both Nil-PVPVA and Cil-PVPVA ASDs was found to switch from rapid, congruent (i.e., simultaneous) release of drug and polymer to incongruent release with slow release of drug. Only ASDs showing congruent release underwent LLPS, with the formation of amorphous drug-rich aggregates (~300nm). Scanning electron microscopy (SEM) and micro-computed tomography (micro-CT) showed the presence of characteristic "pits" on the surface of partially dissolved, incongruently releasing ASD tablets. These most likely arise due to faster polymer release in comparison to drug, whereby the drug-rich composition around these pits was confirmed by energy-dispersive X-ray (EDX) analysis and the surface drug enrichment on the compacts was confirmed by X-ray photoelectron spectroscopy (XPS). This study demonstrates two important findings, firstly, a link between congruent release of drug and polymer and the occurrence of LLPS and secondly, the switch between congruent and incongruent release of drug and polymer is a result of competitive kinetics between phase separation and the release rate of ASD components with minimal influence from drug hydrophobicity for two structural analogues.

摘要

液-液相分离(LLPS)在无定形固体分散体(ASD)溶解后发生,当药物浓度超过“无定形溶解度”时,这是一种可能提高难溶性药物口服生物利用度的制剂的重要特征。本研究的目的是确定影响药物释放速率和程度的标准,从而确定 ASD 溶解时是否发生 LLPS。具体而言,研究了药物的 log P、水合但未溶解的 ASD 基质的相行为以及药物和聚合物的相对溶解速率作为药物载药量的函数,使用尼伐地平(Nil)(ClogP=3.04)和西尼地平(Cil)(ClogP=5.54)作为模型药物。模型聚合物为聚乙烯吡咯烷酮-乙酸乙烯酯共聚物(PVPVA)。制备了不同药物载药量的 Nil-PVPVA 和 Cil-PVPVA ASD。研究了 ASD 片剂中药物和聚合物的表面积归一化溶解速率。在相似且相对较低的药物载药量(<20%w/w 药物)下,发现 Nil-PVPVA 和 Cil-PVPVA ASD 的溶解从药物和聚合物的快速、一致(即同时)释放转变为药物释放缓慢的不一致释放。只有显示一致释放的 ASD 经历了 LLPS,形成了无定形药物丰富的聚集体(~300nm)。扫描电子显微镜(SEM)和微计算机断层扫描(micro-CT)显示,部分溶解、不一致释放的 ASD 片剂表面存在特征性“凹坑”。这些凹坑很可能是由于聚合物释放速度快于药物释放速度所致,通过能量色散 X 射线(EDX)分析证实了这些凹坑周围富含药物的成分,通过 X 射线光电子能谱(XPS)证实了压片上的表面药物富集。这项研究表明了两个重要发现,首先,药物和聚合物的一致释放与 LLPS 的发生之间存在联系,其次,药物和聚合物的一致和不一致释放之间的转变是相分离和 ASD 成分释放速率之间竞争动力学的结果,对于两个结构类似物,药物疏水性的影响最小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验